Answers are grounded in this paper and cite their sources.
Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2012.44.4281 Journal of Clinical Oncology - published online before print October 8, 2012 PMID: 23045586 Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies Adrian WiestnerxAdrian WiestnerSearch for articles by this author Show More National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD https://doi.org/10.1200/JCO.2012.44.4281 First Page Full Text PDF Figures and Tables Supplements © 2012 by American Society of Clinical Oncology
No takes yet. Share an insight, caveat, or question.
Adrian Wiestner (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: